Longobardi Teresa, Jacobs Phillip, Bernstein Charles N
University of Manitoba Department of Internal Medicine, Winnipeg, MB, Canada.
Am J Gastroenterol. 2004 Apr;99(4):650-5. doi: 10.1111/j.1572-0241.2004.04132.x.
There are no cost studies of inflammatory bowel disease (IBD) that describe its impact on resource utilization or treatment costs over long periods of time. Our aim was to determine if there are observable trends in health-care resource utilization by adults with IBD depending on disease duration.
The 1999 U.S. National Health Interview Survey (n = 30,801; N = 195,398,057) included 256 adult cases with IBD who indicated the number of years since the onset of disease. Cases were grouped according to the "number of years with IBD" to distinguish between recent diagnosis (0-5 yr with IBD), long-standing IBD (6-15 yr with IBD), and very long-standing IBD (16-62 yr). A group of non-IBD controls was established and age and gender were controlled for through logistic regression analysis. Odds ratios were computed for resource use including hospitalization, health provider contact, and prescription medication. Population estimates were computed, while accounting for the complex survey design.
When compared with the general population, IBD patients were more likely to visit a specialist and to use prescription medication regardless of disease duration. GP visits were more likely until 15 yr with diagnosed IBD [0-5 yr with IBD: OR = 2.26; 95% CI = (1.21-4.21); 6-15 yr with IBD: OR = 2.73; 95% CI = (1.17-6.37)]. Home care was more likely in the IBD population with long-standing disease [OR = 3.21; 95% CI = (1.22-8.40)]. An emergency room visit [OR = 2.41; 95% CI = (1.49-3.88)] and hospitalization [OR = 2.34; 95% CI = (1.38-3.96)] were more likely in the first 5 yr since diagnosis as was hospitalization and surgical intervention [OR = 2.14; 95% CI = (1.09-4.19)].
Specialist physicians are visited by IBD patients, and prescription medications are provided to treat IBD patients throughout their lives. This is a statistically significant trend that is viewed from onset of the disease to up to 62 yr with IBD. Our results also suggest, at least tentatively, that patients within the first 5 yr after the onset of the disease have a stronger tendency than the general population to visit an emergency room, to be hospitalized, and to have been both hospitalized and to have had surgery. If these results were borne out by further studies, then this would indicate that we can measure the greatest proportion of treatment effects on these resources within a relatively short period.
目前尚无关于炎症性肠病(IBD)的成本研究描述其对长期资源利用或治疗成本的影响。我们的目的是确定患有IBD的成年人在医疗资源利用方面是否存在取决于疾病持续时间的可观察趋势。
1999年美国国家健康访谈调查(n = 30,801;N = 195,398,057)包括256例成年IBD患者,他们指出了疾病发作以来的年数。病例根据“患IBD的年数”进行分组,以区分近期诊断(患IBD 0 - 5年)、长期IBD(患IBD 6 - 15年)和极长期IBD(患IBD 16 - 62年)。建立了一组非IBD对照,并通过逻辑回归分析控制年龄和性别。计算了包括住院、与医疗服务提供者接触和处方药在内的资源使用的比值比。在考虑复杂调查设计的情况下计算了总体估计值。
与普通人群相比,IBD患者无论疾病持续时间如何,都更有可能看专科医生并使用处方药。在确诊IBD后的15年内,看全科医生的可能性更大[患IBD 0 - 5年:比值比 = 2.26;95%置信区间 =(1.21 - 4.21);患IBD 6 - 15年:比值比 = 2.73;95%置信区间 =(1.17 - 6.37)]。长期患病的IBD人群接受家庭护理的可能性更大[比值比 = 3.21;95%置信区间 =(1.22 - 8.40)]。在诊断后的前5年内,急诊就诊[比值比 = 2.41;95%置信区间 =(1.49 - 3.88)]和住院[比值比 = 2.34;95%置信区间 =(1.38 - 3.96)]的可能性更大,住院和手术干预的可能性也更大[比值比 = 2.14;95%置信区间 =(1.09 - 4.19)]。
IBD患者会看专科医生,并在其一生中接受处方药治疗。这是一个从疾病发作到患IBD长达62年都具有统计学意义的趋势。我们的结果还至少初步表明,疾病发作后前5年内的患者比普通人群更倾向于去急诊、住院以及既住院又接受手术。如果这些结果得到进一步研究的证实,那么这将表明我们可以在相对较短的时间内衡量对这些资源的最大比例的治疗效果。